[1]
L.R. Morgan, R.S. Weiner, M.L. Ware, M. Bhandari, T. Mahmood, and P. Friedlander, “Early Phase I Results for 4-Demethyl-4-cholesteryloxypenclo-medine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies ”, J. Can. Res. Updates, vol. 7, no. 3, pp. 75–78, Aug. 2018.